Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- Check7 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the usual study details, with a minimal header and a Home button. This indicates restricted access to the record rather than an update to the study information.SummaryDifference21%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNew study-contact and site entries were added: Sarah Richman, MD and Arthur M Blank Hospital - Children's Healthcare of Atlanta on 2026-09-02 and 2026-08-31. An earlier entry for Neena Kapoor, MD at Arthur M. Blank Hospital (Pediatrics) was removed on 2026-07-31 and 2026-07-29.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page's revision tag updates from v3.6.5 to v3.6.6, indicating a minor version update in the site's metadata. This change does not affect the study details or user-visible content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page revision has been updated to version v3.6.5, indicating a small metadata update to the study record.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now lists a new Data Protection Officer with contact details, while several previous contacts and investigators’ information were removed, reflecting a revision of how to reach the study team.SummaryDifference0.6%

- Check64 days agoChange DetectedThe page shows an updated revision tag, changing from v3.6.3 to v3.6.4, indicating a new site version without altering the study details.SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.